â CFS (Chronic Fatigue Syndrome). CFS is a condition that causes pain, aching, soreness and a general discomfort in the body. It produces chronic bouts of tiredness and fatigue and may be a tenacious symptom of exhaustion. â Persistent lethargy and lack of energy.
DESCRIPTION OF CLINICAL STUDIES. The clinical efficacy of MEGACE Oral Suspension was assessed in two clinical trials. One was a multicenter, randomized, double-blind, placebo-controlled study comparing. megestrol acetate (MA) at doses of 100 mg, 400 mg, and 800 mg per day versus.
Patients received single oral doses of 800 mg/day of MEGACE Oral Suspension for 21 days. Plasma concentration data obtained on day 21 were evaluated for up to 48 hours past the last dose. Mean (Â±1SD) peak plasma concentration (Cmax) of megestrol acetate was 753 (Â±539) ng/mL.